Microtest has invested $7.5 million to expand its offering of pharmaceutical and virology testing services and fill/finish contract manufacturing capabilities. According to Dr. Steve Richter, Ph.D., Microtest’s president and scientific director, the expansion includes constructing and equipping new state-of-the-art pharmaceutical testing laboratory facilities, a series of segregated virology testing laboratories, and new aseptic fill/finish manufacturing facilities, along with the hiring of additional professional staff.

“These include a complete range of pharmaceutical and virology test services that support full in-process and product release testing as well as product stability testing, raw material qualification and assay development/validation. As a manufacturer of pharmaceutical product, the company has all the systems and procedures in place to fully support all the requirements of the FDA, EMEA and any drug-regulating body in the world,” Dr. Richter said.

Microtest will spotlight its expansion of services at the 2006 AAPS National Biotechnology Conference, June 18-21, at the Hynes Convention Center in Boston, MA. Microtest will also offer free qualification of its laboratory services to prospective customers of its virology testing services.